The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against FMC Corporation — Neutral
FMC Accesswire — February 24, 2025LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FMC Corporation ("FMC" or "the Company") (NYSE:FMC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 16, 2023 and February 4, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.

Harmonic Inc. (HLIT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation — Neutral
HLIT Accesswire — February 24, 2025NEW YORK CITY, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Harmonic Inc. ("Harmonic" or "the Company") (NASDAQ:HLIT). Investors who purchased Harmonic securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HLIT.

Semtech Corporation (SMTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation — Neutral
SMTC Accesswire — February 24, 2025NEW YORK CITY, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Semtech Corporation ("Semtech" or "the Company") (NASDAQ:SMTC). Investors who purchased Semtech securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SMTC.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against STAAR Surgical Company (STAA) and Encourages Shareholders to Learn More About the Investigation — Neutral
STAA Accesswire — February 24, 2025NEW YORK CITY, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of STAAR Surgical Company ("STAAR" or "the Company") (NASDAQ:STAA). Investors who purchased STAAR securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/STAA.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Barclays PLC (BCS) and Encourages Investors to Learn More About the Investigation — Neutral
BCS Accesswire — February 24, 2025NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barclays PLC ("Barclays" or "the Company") (NYSE:BCS). Investors who purchased Barclays securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BCS.

A Securities Fraud Lawsuit Has Been Filed Against Constellation Brands, Inc. And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
STZ Accesswire — February 24, 2025LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Constellation Brands, Inc. ("Constellation" or "the Company") (NYSE:STZ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 11, 2024 and January 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 21, 2025.

CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
CDLX Accesswire — February 24, 2025NEW YORK CITY, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cardlytics securities between March 14, 2024 and August 7, 2024, both dates inclusive (the "Class Period").

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out — Neutral
WGS Accesswire — February 24, 2025NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ:WGS). Investors who purchased GeneDx securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WGS.

The Schall Law Firm Invites Investors With Losses In Harmonic Inc. To Join A Securities Fraud Investigation — Neutral
HLIT Accesswire — February 24, 2025LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Harmonic Inc. ("Harmonic" or "the Company") (NASDAQ:HLIT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

A Securities Fraud Lawsuit Has Been Filed Against Target Corporation And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
TGT Accesswire — February 24, 2025LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Target Corporation ("Target" or "the Company") (NYSE:TGT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 26, 2022, and November 19, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before April 1, 2025.

NVO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Novo Nordisk A/S Shareholders Have Opportunity to Lead Class Action Lawsuit! — Neutral
NVO Accesswire — February 24, 2025NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE:NVO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Novo Nordisk securities between November 2, 2022 and December 19, 2024, both dates inclusive (the "Class Period").

EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
EPIX Accesswire — February 24, 2025NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ:EPIX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ESSA securities between December 12, 2023 and October 31, 2024, both dates inclusive (the "Class Period").

Few stocks get this oversold this quickly, especially mega-cap names like UnitedHealth Group Inc. NYSE: UNH. After a 45% rally from March into December, the stock has now collapsed 30%, sending it back to multi-year lows.

WesBanco, Inc. Named One of America's Best Regional Banks by Newsweek — Neutral
WSBC PRNewsWire — February 24, 2025WHEELING, W.Va. , Feb. 24, 2025 /PRNewswire/ -- WesBanco, Inc. (Nasdaq: WSBC), a diversified, multi-state bank holding company, announced today that it has been named to Newsweek's 2025 America's Best Regional Banks.

Best-Performing Leveraged ETFs of Last Week — Positive
BABA BOIL MU SMCI Zacks Investment Research — February 24, 2025These leveraged ETF areas won last week.

UnitedHealth: Well Oversold And Undervalued, Despite Significant Headwinds — Neutral
UNH Seeking Alpha — February 24, 2025UnitedHealth Group faces unconfirmed allegations of inflating risk ratings for reimbursements, causing market panic despite no DOJ confirmation or filed charges. UNH's diversified business model and robust forward guidance suggest the market has likely overreacted to these headwinds. UNH's valuation is arguably undervalued now, while its price action suggests a strong support zone is in place for dip buyers.

Baker Hughes Appoints Ahmed Moghal Chief Financial Officer — Neutral
BKR GlobeNewsWire — February 24, 2025HOUSTON and LONDON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Baker Hughes Company (NASDAQ: BKR) (“Baker Hughes” or the “Company”) on Monday announced that Ahmed Moghal, a highly experienced finance leader who currently serves as chief financial officer (CFO) of our Industrial & Energy Technology (IET) business, has been appointed CFO of the Company, effective immediately. Prior to IET, Moghal held senior positions in various business and corporate roles. In this role, he succeeds Nancy Buese, who, by mutual agreement with the Company, ceased to serve as CFO effective today.

FormFactor Announces the Closing of FICT Transaction — Neutral
FORM GlobeNewsWire — February 24, 2025LIVERMORE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) is pleased to announce the closing of its acquisition, together with North Asia private equity firm MBK Partners (“MBKP”), of FICT Limited (“FICT”). As stated on February 5th, 2025, this transaction secures FormFactor's access to FICT's essential technologies for advanced probe cards, strengthens the long-term partnership between the companies, and positions FICT to continue developing leading-edge technologies for its customers in the semiconductor and high-performance computing markets.

CBAK Energy's 32140 Cells Capture 19% of Global Market Share, Report Shows — Neutral
CBAT GlobeNewsWire — February 24, 2025DALIAN, China, Feb. 24, 2025 (GLOBE NEWSWIRE) -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy" or the "Company"), a leading manufacturer of lithium-ion and sodium-ion batteries and electric energy solutions in China, today announced its significant global market share in the rapidly growing large cylindrical battery segment, which saw remarkable growth in 2024. According to the latest report from Start Point Institute of Research (“SPIR Report”), global shipments of Series 32 large cylindrical batteries, which includes the Company's 32140 cylindrical cells, surged to 102 million units in 2024, with a year-over-year increase of 14.29%.

LegalZoom to Participate in March 2025 Investor Conferences — Neutral
LZ GlobeNewsWire — February 24, 2025MOUNTAIN VIEW, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- LegalZoom.com, Inc. (Nasdaq: LZ), a leading online platform for legal services, today announced that Jeff Stibel, Chairman and Chief Executive Officer, and Noel Watson, Chief Operating Officer and Chief Financial Officer, will participate in the following upcoming investor conferences:
